Skip to main content
Pathology & Laboratory Medicine

Pathology Advanced Translational Research Unit (PATRU) section navigation

Our Next Steps

  • Develop novel immune based therapies based on basic driven concepts
  • Cell based therapies; develop our platform with Winship and GRA
  • Immune check point blockers in cancer and HIV
  • TGF b/ IL-10 for cancer and HIV
  • Modulators of the microbiome and metabolome
  • Develop concept driven clinical trials of immune based therapies in cancer and HIV
  • Generate a data base of predictors of successful immune interventions
  • Train a new breed of scientists at the crossroad of computational science, multi-OMICs platforms and experimental medicine
  • Over the next five years, (PATRU) will provide training to graduate and undergraduate students to develop expertise and knowledge in the area of systems immunology, vaccinology and bioinformatics.

We have been funded by a diverse group of sponsors including the National Institutes of Health, the Bill and Melinda Gates Foundation, the American Foundation for AIDS Research, the Fred Hutchinson Cancer Research Center, Gilead Sciences Incorporation, Merck Sharp & Dohme Corporation, and more.